Velocity Clinical Research

Velocity Clinical Research, located at 1214 North Fant Street in Anderson, South Carolina, is a leading research site known for its success in respiratory trials such as COPD and Asthma. Established in 2013 as part of VitaLink Research and acquired by Velocity in 2021, the Anderson location has expanded its therapeutic diversity to include trials in diabetes, Alzheimer's, and various vaccines. All trials are conducted according to ICH and FDA guidelines, ensuring compliance with GCP standards.

Conveniently situated near Downtown Anderson, the site shares a building with a Pulmonology office, providing easy access to potential patients. With ample patient parking available and located just over a mile from the local hospital, the Anderson team is dedicated to being a resource for study volunteers and providing compassionate patient care while advancing medicine through research.

Led by Principal Investigator Charles Thompson, MD, and Site Manager Stephanie Gilreath, RRT, CCRC, the Anderson team is committed to conducting high-quality research in a professional and caring environment. With experts who have supported clinical trials for decades, Velocity ensures that all trials are overseen by the U.S. FDA and conducted by board-certified physicians and trained research staff.

From gastrointestinal disease to asthma, Alzheimer's, flu vaccines, liver disease, Lyme disease, and more, Velocity Clinical Research is at the forefront of cutting-edge research. Joining a clinical trial with Velocity means contributing to the development of new medicines, treatments, and cures that could improve human health and wellbeing. Trust Velocity for your clinical trial needs and be a part of advancing medicine for a better future.